Professor of Medicine Loyola University Chicago Stritch School of Medicine
Infectious Disease
Dr. Dale N. Gerding, MD
|
|
Give Review
Dale N. Gerding, MD works in the field of Infectious Disease. He attended University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He has 1 awards "Whos Who in Medicine and Healthcare". Dr. Dale N. Gerding is a published doctor. He has 89 papers published. The most current publication "Breakthroughs in the treatment and prevention of Clostridium difficile infection."
Publications
- Breakthroughs in the treatment and prevention of Clostridium difficile infection.
- Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection.
- Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse.
- Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection (CDI) with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Str...
- Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027.
- A US Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile Associated Diarrheal Isolates and their Susceptibility to Fidaxomicin.
- Molecular Epidemiology of Clostridium difficile Infections in Children: A Retrospective Cohort Study.
- Burden of Clostridium difficile infection in the United States.
- Differential immunodetection of toxin B from highly virulent C. difficile BI/NAP-1/027.
- Lack of Evidence for an Unmet Need to Treat Clostridium difficile Infection in Infants Under 2 Years of Age: Expert Recommendations on How to Address This Issue.
- Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies.
- A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.
- Is pediatric Clostridium difficile infection associated with prior antibiotic exposure?
- Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update.
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results from Two Multinational, Randomized, Controlled Trials.
- Introduction to "a compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates".
- Community-Associated Clostridium difficile Infection among Veterans with Spinal Cord Injury and Disorder.
- Protection from Clostridium difficile Infection in CD4 T Cell- and Polymeric Immunoglobulin Receptor-Deficient Mice.
- Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
- Kibdelomycin is a potent and selective agent against toxigenic Clostridium difficile.
- Spore Formation and Toxin Production in Clostridium difficile Biofilms.
- Protection from Clostridium difficile infection in CD4 T cell and polymeric immunoglobulin receptor deficient mice.
- Utility of a Commercial Polymerase Chain Reaction Assay and a Clinical Prediction Rule for Detection of Asymptomatic Carriers of Toxigenic Clostridium difficile.
- Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance.
- Non-Toxigenic Clostridium difficile Protects Hamsters Against Challenge with Historic and Epidemic Toxigenic BI/NAP1/027 C. difficile.
- Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011.
- Does infection with Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?
- Effectiveness of Hand Hygiene for Removal of Clostridium difficile Spores from Hands.
- Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy.
- Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
- Sustained Clinical Response as an Endpoint in Treatment Trials of Clostridium difficile-Associated Diarrhea.
- Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain.
- Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colo...
- Comparative susceptibilities of fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two fidaxomicin phase III trials of Cl...
- Comparison of Strain Typing Results for Clostridium difficile Isolates from North America.
- A Fourteen Genome Comparison Identifies DNA Markers for Severe Disease-Associated Strains of Clostridium difficile.
- Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
- Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clos...
- Management of Clostridium difficile infection: thinking inside and outside the box.
- Global epidemiology of Clostridium difficile infection in 2010.
- Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
- Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
- Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.
- Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands.
- Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
- Workshop on immunizations in older adults: identifying future research agendas.
- Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restric...
- Treatment with monoclonal antibodies against Clostridium difficile toxins.
- Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.
- Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.
- Antimotility agents for the treatment of Clostridium difficile infection: is the juice worth the squeeze?
- A mouse model of Clostridium difficile-associated disease.
- A compendium of strategies to prevent healthcare-associated infections in acute care hospitals.
- Strategies to prevent central line-associated bloodstream infections in acute care hospitals.
- Strategies to prevent ventilator-associated pneumonia in acute care hospitals.
- Strategies to prevent catheter-associated urinary tract infections in acute care hospitals.
- Strategies to prevent surgical site infections in acute care hospitals.
- Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals.
- Strategies to prevent clostridium difficile infections in acute care hospitals.
- Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
- Toxinotype V Clostridium difficile in humans and food animals.
- Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis,...
- Clinical recognition and diagnosis of Clostridium difficile infection.
- Treatment of Clostridium difficile infection.
- Measures to control and prevent Clostridium difficile infection.
- Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
- Clostridium difficile-associated disease treatment response depends on definition of cure.
- In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
- Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital.
- Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
- New definitions will help, but cultures are critical for resolving unanswered questions about Clostridium difficile.
- Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.
- Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
- Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure.
- An epidemic, toxin gene-variant strain of Clostridium difficile.
- Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
- A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.
- Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases.
- Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.
- Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.
- Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins.
- International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.
- Colonization for the prevention of Clostridium difficile disease in hamsters.
- Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatients.
- Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospital.
- Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals.
- A simulation-based assessment of strategies to control clostridium difficile transmission and infection.
- Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile.
Schools
University of Mn Med Sch
Peter Bent Brigham Hospital
University Minn Hospital
Va Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
University of Minnesota at Fairview -
Brigham and Women's Hospital -
University of Minnesota Medical School